Product
Methyloprednisolone
1 clinical trial
3 indications
Indication
Relapsing Multiple SclerosisIndication
Multiple SclerosisIndication
Primary ProgressiveClinical trial
An Open-Label, Multicenter, Biomarker Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Patients With Relapsing Multiple Sclerosis or Primary Progressive Multiple SclerosisStatus: Completed, Estimated PCD: 2023-04-11